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INTRODUCTION
Neisseria gonorrhoeae (N. gonorrhoeae) is the causative agent 
of gonorrhea, a sexually transmitted disease, and is one of the 
most prevalent sexually-transmitted pathogens worldwide.1 
The incidence of N. gonorrhoeae infection has decreased in 
many developed countries,2 although it is still prevalent in 
many developing counties,1 and has even recently increased 
in a few developed countries.3 According to the Centers for 
Disease Control and Prevention (CDC) in the United States, a 
total of 321849 cases of gonococcal infections were reported 
in 2011; however, the CDC estimates that the incidence could 
exceed 800000 cases annually in the United States alone.4 In 
Korea, the Health Insurance Review and Assessment Service 
reported that 40038 cases of gonococcal infections were charged 
for pay in 2012.5
N. gonorrhoeae is considered to be a pathogen, and can only 
be transmitted from human to human via various sexual prac-
tices.6 Thus, infection control is very important to prevent the 
dissemination of N. gonorrhoeae among the general popula-
tion. However, most female and a few male patients who have 
Increasing Incidence of High-Level Tetracycline-
Resistant Neisseria gonorrhoeae due to 
Clonal Spread and Foreign Import
Hyukmin Lee1, Hyunsoo Kim2, Hyo Jin Kim2, Young Hee Suh2, Dongeun Yong2, Seok Hoon Jeong2,  
Kyungwon Lee2, and Yunsop Chong2
1Department of Laboratory Medicine, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon;
2Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Purpose: The detection of high-level tetracycline-resistant strains of Neisseria gonorrhoeae (TRNG) can make important epide-
miological contributions that are relevant to controlling infections from this pathogen. In this study, we aimed to determine the 
incidence of TRNG isolates over time and also to investigate the characteristics and genetic epidemiology of these TRNG isolates 
in Korea.
Materials and Methods: The antimicrobial susceptibilities of 601 isolates of N. gonorrhoeae from 2004 to 2011 were tested by 
standard Clinical and Laboratory Standards Institute methods. To determine the molecular epidemiological relatedness, N. gonor-
rhoeae multi-antigen sequence typing was performed.
Results: The incidence of TRNG increased from 2% in 2004 to 21% in 2011. The minimum inhibitory concentration distributions 
of ceftriaxone and susceptibility of ciprofloxacin in TRNG were different from non-TRNG and varied according to the year of iso-
lation. Most of the TRNG isolates collected from 2004 to 2007 exhibited genetic relatedness, with sequence type (ST) 1798 being the 
most common. From 2008 to 2011, the STs of the isolates became more variable and introduction of genetically unrelated TRNG 
were noted.
Conclusion: The increased incidence of TRNG strains until 2007 appears to be due, at least in part, to clonal spread. However, we 
propose that the emergence of various STs since 2008 could be associated with foreign import.
Key Words:  Neisseria gonorrhoeae, tetracycline, antimicrobial resistance, epidemiology, NG-MAST
Yonsei Med J 2016 Mar;57(2):350-357
http://dx.doi.org/10.3349/ymj.2016.57.2.350
Original Article 
pISSN: 0513-5796 · eISSN: 1976-2437
Received: January 16, 2015   Revised: May 6, 2015
Accepted: June 15, 2015
Corresponding author: Dr. Kyungwon Lee, Department of Laboratory Medicine 
and Research Institute of Bacterial Resistance, Yonsei University College of Medi-
cine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Tel: 82-2-2228-2446, Fax: 82-2-313-0908, E-mail: leekcp@yuhs.ac
•The authors have no financial conflicts of interest.
© Copyright: Yonsei University College of Medicine 2016
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
351http://dx.doi.org/10.3349/ymj.2016.57.2.350
Hyukmin Lee, et al.
gonorrhea do not exhibit any apparent symptoms,7 despite the 
clinical significance of this disease. The lack of obvious symp-
toms therefore adds a layer of difficulty to controlling its spread. 
Furthermore, the emergence and spread of resistance to vari-
ous antimicrobial agents has created many difficulties in the 
management of gonococcal infections.8,9 Drug-resistant N. gon-
orrhoeae was classified as a microorganism with a threat level 
of “urgent” by the CDC in 2013.4 Thus, epidemiological under-
standing and surveillance programs may need to be imple-
mented in order to prevent the dissemination of gonorrhea and 
overcome the problem of antimicrobial resistance in N. gon-
orrhoeae.10
Tetracycline is a historic drug and cannot be used any lon-
ger to treat gonorrhea in many countries due to the dissemi-
nation of tetracycline-resistant strains of N. gonorrhoeae, which 
have become very common over the past several decades, in-
cluding in Korea.11 Since tetracycline is not used anymore, the 
detection of tetracycline resistance is clinically insignificant. 
However, surveillance of trends in high-level resistance to tet-
racycline caused by plasmid transfer can be helpful in under-
standing the epidemiological aspects of gonococcal infections 
and controlling these infections, because such monitoring 
enables the detection of clonal variations.12 In this study, we 
aimed to determine the incidence of high-level tetracycline-
resistant N. gonorrhoeae (TRNG) isolates over many years and 
to investigate the characteristics and genetic epidemiology of 
TRNG in Korea. 
MATERIALS AND METHODS
N. gonorrhoeae isolates
A total of 601 N. gonorrhoeae isolates were collected from 
symptomatic patients with urethritis and sex workers between 
2004 and 2011 in Korea. The number of isolates collected each 
year ranged from 47 to 135. Most N. gonorrhoeae isolates were 
obtained from primary urological clinics, which were widely 
distributed across the country. Modified Thayer-Martin agar 
plates (Becton Dickinson, Cockeysville, MD, USA) were used 
for primary isolation, and conventional biochemical tests, in-
cluding Gram stain and the Vitek NHI System (bioMerieux, 
Marcy l’Etoile, France), were used for species identification. 
Isolates were stored in 20 per cent skim milk (Difco, Detroit, 
MI, USA) at -70°C until ready for analysis.
Antimicrobial susceptibility testing
High-level resistance to tetracycline was tested by the disk dif-
fusion and agar dilution methods. The disk diffusion test, which 
is recommended by the Clinical and Laboratory Standards In-
stitute (CLSI), was performed using a disk containing 30 μg of 
tetracycline (Becton Dickinson).13,14 Fifty-eight isolates of TRNG 
and 304 isolates of non-TRNG were randomly selected to de-
termine the minimum inhibitory concentrations (MICs) of var-
ious antimicrobial agents, including tetracycline, and to com-
pare resistances. Resistance to penicillin G (Sigma Chemical, 
Saint Louis, MO, USA), ceftriaxone (Hanmi, Seoul, Korea), 
spectinomycin (Kuk Je, Seoul, Korea), cefixime (Dong-A, Seoul, 
Korea), tetracycline (Pfizer Korea, Seoul, Korea), and cipro-
floxacin (Bayer Korea, Seoul, Korea) were tested by the CLSI 
agar dilution method,13,15 using a GC II agar base supplement-
ed with 1% IsoVitaleX (Becton Dickinson). Approximately 104 
colony forming unit of each isolate were inoculated onto the 
agar plates with a Steer’s replicator (Craft Machine, Chester, 
PA, USA); plates were then incubated in a 5% CO2 atmosphere 
at 35°C for 24 h. The American Type Culture Collection (ATCC) 
49226, World Health Organization (WHO) A 100A6, WHO B 
100A7, WHO G 100I1, WHO J 100I4, WHO K 300J4, and WHO L 
00G 1003 OKKA20 strains of N. gonorrhoeae were used as 
quality control strains. 
Molecular epidemiological study
To determine the molecular epidemiological relatedness of 
the TRNG strains, N. gonorrhoeae multi-antigen sequence typ-
ing (NG-MAST) and pulsed-field gel electrophoresis (PFGE) 
were carried out for 58 and 36 isolates of TRNG, and NG-MAST 
for 156 isolates of non-TRNG was tested.12 NG-MAST was per-
formed according to the guidelines outlined on the NG-MAST 
homepage (http://www.ng-mast.net), using primers for the 
porB and tbpB genes.16 Polymerase chain reaction (PCR) was 
carried out in a total volume of 20 μL, containing 1 μL of heat-
extracted template DNA, 10 pmol of each primer, and a PreMix 
(Bioneer, Daejeon, Korea) master mix containing 1 U of Taq 
DNA polymerase. Thermocycling conditions included 25 cy-
cles of 95°C for 30 seconds, either 58°C for 30 seconds for porB 
or 69°C for 30 seconds for tbpB, and 72°C for 1 minute. Reac-
tions also included an initial denaturation step at 95°C for 4 
minutes and a final extension step at 72°C for 10 minutes, and 
were performed using a thermal cycler (Eppendorf, Hamburg, 
Germany). The resultant PCR products were purified using a 
DNA extraction kit (Qiagen, Hilden, Germany), and the nucleo-
tide sequences of the PCR-generated amplicons were analyzed 
at a commercial laboratory (Macrogen, Seoul, Korea). The se-
quences of porB and tbpB were analyzed using the NG-MAST 
homepage to assign allele numbers and to determine the se-
quence type (ST) of each isolate. Two phylogenetic trees of por 
genes for TRNG and non-TRNG and tbpB genes for TRNG were 
generated with Molecular Evolutionary Genetics Analysis ver-
sion 6 software (http://www.megasoftware.net) using the 
Neighbor-Joining method. 
PFGE was performed for 36 isolates, which showed different 
NG-MAST STs. Briefly, one loopful of cells was suspended in 1 
mL of saline ethylenediaminetetraacetic acid (EDTA) solution 
and used to prepare genomic DNA plugs, which were digested 
with NheI (Takara, Tokyo, Japan) for 18 hours at 35°C. Frag-
ments were then resolved using switch times of 0.5 seconds 
(initial) and 54 s (final), and a running time of 20 h at 6 V/cm 
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with a CHEF DR II instrument (Bio-Rad, Hercules, CA, USA). 
PFGE banding pattern similarities were determined using the 
Dice coefficients and the unweighted pair group method, using 
arithmetic averages obtained by the clustering method. Calcu-
lations were performed using Molecular Analyst Fingerprinting 
software (v. 1.12; Bio-Rad), and dendrogram was generated 
from these calculations.
Ethical standards
This study has been granted an exemption from requiring eth-
ics approval, because it was performed as one of project of na-
tional surveillance program supported by Korean Centers for 
Disease Control and Preventions (2012-E44006-00). 
RESULTS 
Incidence of TRNG
A total of 92 isolates (15%) of TRNG were identified from 2004 
to 2011. The proportion of TRNG was low in 2004 (2%, 2/91); 
however, it increased to 10% (5/48) in 2005. This incidence of 
TRNG continued to steadily increase, reaching 24% (16/66) in 
2007. The range of the incidence of TRNG from 2008 to 2011 
was 15–21% (Fig. 1).
Antimicrobial susceptibility
None of the non-TRNG isolates were susceptible to penicillin 
G; however, all of the non-TRNG isolates showed susceptibili-
ty to ceftriaxone, cefixime, and spectinomycin. The MIC50 and 
MIC90 of ceftriaxone and cefixime were 0.06 mg/L and 0.12 
mg/L, respectively. The MIC50 and MIC90 of ciprofloxacin were 
8 mg/L and 16 mg/L, and 15% of all isolates were susceptible to 
ciprofloxacin. Like the non-TRNG isolates, none of the TRNG 
isolates were susceptible to penicillin G; meanwhile, all TRNG 
isolates were susceptible to ceftriaxone, cefixime, and spec-
tinomycin. However, the MIC50s and MIC90s of ceftriaxone and 
cefixime were very low (≤0.008 mg/L), unlike for the non-TRNG 
Fig. 1. Summary of the number and percentage of TRNG isolates ob-
tained in Korea by year. TRNG, high-level tetracycline-resistant Neisse-
ria gonorrhoeae.
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Table 2. NG-MAST Sequence Types of TRNG Isolates Obtained from 2004 to 2011
Yr
NG-MAST No.
isolated
Range of MIC (mg/L)
ST porB tbpB Penicillin Ceftriaxone Cefixime SPT CIP
2004–2007
7894 1146 33 1  0.25 ≤0.008 ≤0.008 16 ≤0.008
1798 1146 455 6
 0.25 ≤0.008 ≤0.008 32 ≤0.008
 0.25 ≤0.008 ≤0.008 32 ≤0.008
 0.25 ≤0.008 ≤0.008 32 ≤0.008
 0.5 ≤0.008 ≤0.008 32 ≤0.008
 0.5 ≤0.008 ≤0.008 32 8
1 ≤0.008 ≤0.008 32 ≤0.008
6327 95 455 2
 0.25 ≤0.008 ≤0.008 16  0.12
 0.5 ≤0.008 ≤0.008 32 ≤0.008
7927 609 455 1 1 ≤0.008 ≤0.008 32 ≤0.008
3945 2392 860 2 0.25–0.5 ≤0.008 ≤0.008 32 ≤0.008
2008–2009
7689 1146 21 2
≤0.006 ≤0.008 ≤0.008 32 4
 0.12 ≤0.008 ≤0.008 16 4
7928 1049 21 2
 0.5  0.06  0.12 32 8
1  0.25  0.06 32 8
7886 2411 33 2
≤0.06 ≤0.008 ≤0.008 16 2
0.12 ≤0.008 ≤0.008 32 4
7929 1992 33 1 129  0.03 0.015 32 16
1458 90 60 1 0.12 ≤0.008 ≤0.008 32  0.25
7903 488 66 1 129 ≤0.008 0.015 16 4
1405 543 110 1 129  0.06  0.12 16 4
1730 161 272 1 129 ≤0.008 ≤0.008 16 2
4001 2430 272 1 129 ≤0.008 ≤0.008 16 2
1798 1146 455 7
≤0.06 ≤0.008 ≤0.008 32 ≤0.008
 0.12 ≤0.008 ≤0.008 32 ≤0.008
 0.12 ≤0.008 ≤0.008 32 4
 0.12 ≤0.008 ≤0.008 32 4
 0.25 ≤0.008 ≤0.008 32 ≤0.008
 0.25 ≤0.008 0.015 32 ≤0.008
 0.25 ≤0.008 ≤0.008 32 ≤0.008
6327 95 455 2
 0.25 ≤0.008 ≤0.008 32  0.12
 0.25 ≤0.008 ≤0.008 32  0.12
7915 1002 455 1  0.05 ≤0.008 ≤0.008 32 ≤0.008
7921 2403 455 2
≤0.06 ≤0.008 ≤0.008 32 ≤0.008
0.5 ≤0.008 ≤0.008 32 ≤0.008
2010–2011
7301 23 4 1  0.25  0.03  0.25 16 4
7933 2139 4 1 64 0.015  0.03 32 2
3425 1053 21 1 >128 ≤0.008 ≤0.008 32 8
4764 2874 21 1  0.25 0.06  0.12 16 4
7688 23 21 1 1 0.06  0.06 16 4
7914 2405 21 1 2  0.06  0.12 16 16
8052 4801 21 1 1  0.06  0.06 16 4
8193 4917 21 1 1  0.06  0.12 8 8
8867 5219 21 1 4  0.12  0.5 32 64
7936 369 33 1 1 0.015 0.015 16 4
7934 2053 129 1 1 ≤0.008 ≤0.008 32 ≤0.008
7925 104 330 1  0.25  0.03  0.06 16 4
7924 23 455 1  0.25 ≤0.008 ≤0.008 16 ≤0.008
7935 147 455 1 128  0.03  0.12 32 2
7937 428 455 1  0.12 ≤0.008 ≤0.008 16  0.12
NG-MAST, Neisseria gonorrhoeae multi-antigen sequence typing; TRNG, high-level tetracycline-resistant Neisseria gonorrhoeae; ST, sequence type; MIC, mini-
mum inhibitory concentration; SPT, spectinomycin; CIP, ciprofloxacin.
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isolates. The rate of susceptibility to ciprofloxacin among the 
TRNG isolates was 61%, and the MIC50 and MIC90 of ciproflox-
acin were ≤0.008 mg/L and 4 mg/L, respectively (Table 1).
From 2004 to 2011, no definite changes in antimicrobial 
susceptibility were noted in the non-TRNG isolates; however, 
the susceptibility to cephalosporins and the rate of suscepti-
bility to ciprofloxacin deteriorated in the TRNG isolates. The 
MIC50 and MIC90 of ceftriaxone were ≤0.008 mg/L and ≤0.008 
mg/L in 2004–2007, ≤0.008 mg/L and 0.06 mg/L in 2008–2009, 
and 0.03 mg/L and 0.06 mg/L in 2010–2011, respectively. The 
MIC50 of ciprofloxacin and rate of susceptibility were ≤0.008 
mg/L and 93% in 2004–2007, 2 mg/L and 44% in 2008–2009, 
and 4 mg/L and 18% in 2010–2011, respectively (Table 1).
Molecular epidemiology
From 2004 to 2007, five different STs were found in 12 isolates; 
of these, six isolates belonged to ST1798 (50%) according to 
NG-MAST analysis, and nine isolates contained the tbpB 455 
allele. All isolates collected in this period were highly suscep-
tible to both ceftriaxone and cefixime, and all isolates except 
one showed susceptibility to ciprofloxacin. During 2008 and 
2009, the STs of the isolates became more variable, with 13 
different STs observed in 24 isolates; however, ST1798 remained 
the most prominent ST (7/24). Most of the N. gonorrhoeae iso-
lates harboring the tbpB 455 allele showed susceptibility to 
ciprofloxacin, but other isolates that harbored the tbpB 21, 33, 
60, 66, 110, or 272 allele were either intermediately or com-
pletely resistant. During 2010 and 2011, 15 different STs were 
noted; moreover, no two isolates shared the same ST. The most 
common tbpB allele was 21 (7/15), and only three isolates har-
bored the tbpB 455 allele, even though this allele had been 
highly prevalent during previous periods. Most of the isolates 
were resistant to ciprofloxacin, except the ST7934 and ST7924 
isolates (Table 2). Dendrogram analysis revealed that most iso-
lates were genetically unrelated, and suggested the sporadic 
emergence of various STs from 2007 to 2011. Some isolates har-
boring the same tbpB allele belonged to various STs, which 
were located distantly from one another on the dendrogram of 
TRNG (data not shown). In the phylogenetic tree, which was 
composed for the por gene for TRNG and non-TRNG isolates 
Fig. 2. Evolutionary relationships of por gene of TRNG and non-TRNG isolated in Korea during 2006 (A) and 2010–2011 (B). The phylogenetic tree was 
drawn by MEGA6 software using the Neighbor-Joining method. Allele numbers belonging to TRNG are marked with a red dot. TRNG, high-level tetra-
cycline-resistnat Neisseria gonorhoeae; MEGA6, Molecular Evolutionary Genetics Analysis version 6.
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in 2006, three TRNG isolates had por 1146, while another ex-
hibited por 2392; both alleles were genetically related to each 
other. However, the por gene of TRNG varied during 2010 and 
2011, and the location of por gene alleles were dispersed th-
roughout the phylogenetic tree (Fig. 2). In the phylogenetic tree 
of tbpB genes, which was composed for the 11 tbpB alleles 
identified from 2004 to 2011, two clusters were noted. The 
large cluster consisted of tbpB 33, 60, 110, 129, 330, 455, and 
860, whereas the smaller cluster comprised tbpB 4, 21, 66, and 
272 (Fig. 3). 
DISCUSSION
The dissemination of multidrug-resistant strains of N. gonor-
rhoeae and the recent emergence of resistance to extended-
spectrum cephalosporins, including ceftriaxone, pose major 
problems for the management of gonorrhea.17-19 A particular 
difficulty in achieving effective antimicrobial treatment is that 
it requires active infection control, based on precise epidemi-
ological information, to overcome gonorrheal infections. Tetra-
cycline resistance can be caused by chromosomal mutations 
in several genes, such as mtrR, or by the transfer of plasmids 
harboring the tetM gene.20,21
In Korea, tetracycline resistance has been widely dissemi-
nated since the late 1960s, and almost all isolates have been 
tetracycline-resistant for several decades.11,22,23 However, in 
spite of the prevalence of tetracycline resistance, the incidence 
of TRNG remained relatively low until the early 2000s, ranging 
from 0–1% in the late 1990’s and 1–4% in the early 2000’s.12,22 
In 2004, the incidence of TRNG was still low (2%) in Korea; 
however, high-level tetracycline resistance increased to 10% 
in 2005 and again up to 24% in 2007. The reasons underlying 
this increase in TRNG isolates are not yet clear. However, hy-
potheses can be generated by taking into account clonal spread, 
horizontal spread, and foreign import. First, clonal spread may 
have contributed to the rise of TRNG in Korea. In antimicrobi-
al susceptibility comparisons, TRNG isolates showed differenc-
es in their cephalosporin and ciprofloxacin susceptibilities, 
compared with non-TRNG isolates. The MIC50s and MIC90s of 
ceftriaxone and cefixime for TRNG isolates were eight times 
lower than for non-TRNG isolates; furthermore, the rate of cip-
rofloxacin susceptibility was 61% in TRNG isolates, but only 
15% in non-TRNG isolates. This difference can be interpreted 
in the context of clonal differences and expansion of TRNG 
clones; moreover, clonal spread of TRNG isolates has been ob-
served in the other countries including UK and Argentina.24,25 
The importance of clonal dissemination is also supported by 
the observation that most of the TRNG isolates obtained from 
2004 to 2007 were of the ST1798 subtype and harbored the 
tbpB 455 allele (ST1798, ST6327, and ST7927); moreover, these 
isolates were placed into one common phylogenic cluster, sh-
ared with the tbpB 33 (ST7894) and tbpB 860 (ST3945) alleles.
However, the susceptibilities of TRNG isolates to ceftriax-
one and ciprofloxacin were not consistent, and decreased over 
time. From 2004 to 2007, the MIC50s and MIC90s of TRNG iso-
lates to ceftriaxone and cefixime were lower than 0.008 mg/L. 
From 2008 to 2009, the MIC90s of ceftriaxone and cefixime in-
creased to 0.06 mg/L; moreover, the MIC50s of ceftriaxone and 
cefixime also increased to 0.03 mg/L and 0.06 mg/L, respec-
tively. The MIC50 of ciprofloxacin and the rate of resistance to 
ciprofloxacin also increased over time. These changes in the 
antimicrobial susceptibilities of TRNG isolates were also re-
ported in India by Bala, et al.26 Such changes can result from 
the horizontal spread of a plasmid bearing the tetM gene to 
resistant non-TRNG isolates, because plasmids can move be-
tween isolates.27-29 This phenomenon may provide a second 
explanation for the increase in TRNG isolates. However, con-
sidering the fact that the selective pressure for tetracycline 
was very low in Korea since the 1990s,22 horizontal transfer 
seems a less likely explanation than the other alternatives.
Notwithstanding, many isolates of TRNG were located at a 
great distance from one another in the dendrogram and phy-
logenetic tree in the period of increasing prevalence of TRNG. 
In 2006, three of four TRNG isolates belonged to ST1798 har-
boring por 1146 allele, while the remaining isolate exhibited 
por 2392, revealing a genetic relationship indicative of clonal 
expansion of TRNG. However, this clonal relationship was not 
found during 2010 and 2011. TRNG collected during this peri-
od seemed to appear sporadically, and their appearance is not 
easily explained by clonal spread. During this period, half of 
the por alleles (8/16) were located outside of the main cluster 
that consisted of por 23, 2053, 2874, 4270, 4801, 4917, 6288, and 
6297, which may indicate emergence of divergent TRNG strains. 
The emergence of these divergent isolates can suppose that 
the increase of TRNG prevalence can result from foreign im-
port when we take into consideration that consistent collection 
strategies have been sustained since 2004. This hypothesis 
also can be supported by a change in the tbpB allele through-
out the late 2000s in Korea. From 2004 to 2007, the majority of 
Fig. 3. Phylogenetic tree of the tbpB alleles harbored by various TRNG 
isolates obtained in Korea from 2004 to 2011 made by MEGA6 software 
using the Neighbor-Joining method. TRNG, high-level tetracycline-re-
sistnat Neisseria gonorhoeae; MEGA6, Molecular Evolutionary Genet-
ics Analysis version 6.
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all TRNG isolates in Korea belonged to STs bearing the tbpB 455 
allele (ST1798, ST6327, and ST7927); however, STs harboring 
the tbpB 21 allele (ST7689 and ST7928) emerged in 2008, mak-
ing this allele the most prominent allele during 2010 and 2011. 
Strains harboring the tbpB 455 or tbpB 21 allele showed many 
differences in their individual allele sequences, and this can 
suggest the emergence of new STs resulting from foreign im-
port.30 In the Asia-Pacific region, the proportion of TRNG iso-
lates varies according to country.31,32 In 2004, 72% of all N. gon-
orrhoeae isolates in Singapore were TRNG, 34% in China, 20% 
in Vietnam and 8% in the Philippines. Japan exhibited a low 
incidence (2%) of TRNG, similar to that of Korea.31 In 2010, the 
incidence of TRNG isolates in Western-Pacific countries ranged 
from moderate to high, with incidences of 71–100% in Brunei; 
35–75% in Mongolia, China, Hong Kong, Singapore, and Viet-
nam; and 10–34% in Australia, India, the Philippines, and Thai-
land.32 It is difficult to thoroughly assess the extent of foreign 
import of some pathogens; however, the recent worldwide 
spread of cefixime-resistant strains of N. gonorrhoeae33 and 
genetic relatedness of ceftriaxone-resistant strains isolated from 
France and Spain may be a convincing examples of foreign im-
port.34 In our study, the emergence of new STs, the changes in 
tbpB allele distribution, the dispersed distribution of isolates 
sharing the same tpbB allele in the dendrogram, and the dis-
persed distribution of isolates of various STs according to year 
in the dendrogram appear to support the idea of foreign im-
port. This import of TRNG strains from other countries can be 
a source of another severe antimicrobial resistance, including 
ceftriaxone resistance, and may require additional programs 
to prevent it. However, further investigations employing addi-
tional approaches, such as multilocus sequence typing, should 
be performed to test this hypothesis.
In conclusion, the increase in the incidence of TRNG strains 
until 2007 appears to be due, at least in part, to clonal spread. 
However, we propose that the emergence of various STs since 
2008 is due to foreign import and/or clonal evolution. Further 
investigations are required to fully determine the relevant 
changes in TRNG epidemiology.
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